- Lung Cancer Basics
August 10, 2017 - The FDA Oncology Center of Excellence (OCE) was established in January 2017 as a key component of the Cancer Moonshot Initiative, and it is an indispensable partner to the NCI, which is focused on accelerating clinical and translational research in key areas identified by the Moonshot’s Blue Ribbon Panel. As the NCI and the FDA work in partnership to implement key elements of the Beau Biden Cancer Moonshot Initiative, a national coalition including LCA, called on Congressional leaders to ensure that these agencies have the legislative authority required to fully collaborate when and how appropriate. Specifically, providing transfer authority between the NCI and the FDA for Moonshot Initiative efforts will ensure the FDA OCE can fulfill its vital mission of translating the science to accelerate the delivery of safe and effective therapies to cancer patients.
Click here to read the full letter.